Valvular heart disease
Disease2 papers
- Humans1
Trial sponsors
1 trialPhase 21,005 people
Frontier Interdisciplinary Direction of Intelligent Biomanufacturing, Central South University
1 trialPhase 2226 people
Funding
National Heart, Lung, and Blood InstituteUS$817.1k1 grant since 2024
Latest
14The Journal of Nutrition, Health & AgingHumans
Intrinsic capacity outperforms frailty in cardiac rehab outcomes
In 551 older patients, intrinsic capacity showed a stronger link to post-rehabilitation walking outcomes (β = 0.571) than the frailty index (β =…In 551 older patients, intrinsic capacity showed a stronger link to post-rehabilitation walking outcomes (β = 0.571) than the frailty index (β = -0.281).
European CardiologyReview
Lipoprotein(a) and Aortic Stenosis: From Genetic Risk to Emerging Therapeutic Strategies
European Journal of Preventive CardiologyHumans
Metabolic obesity phenotypes and degenerative valvular heart disease: A cohort study
European Journal of Heart FailureHuman trial
Treatment effects of dapagliflozin in patients with aortic stenosis undergoing transcatheter aortic valve implantation across left ventricular ejection fraction
AHA Scientific Sessions 2025 AbstractHumans
Impact of Sodium Glucose Cotransporter 2-Inhibitors in Valvular Heart Disease
AHA Scientific Sessions 2025 AbstractHumans
Circadian Disruption by Shift Work Drives Aortic Valve Calcification Through BMAL1-SEMA6D-PPARγ Axis Inhibition
AHA Scientific Sessions 2025 AbstractHumans